Understanding the polypharmacological anticancer effects of Xiao Chai Hu Tang via a computational pharmacological model
- PMID: 24926384
- PMCID: PMC4043560
- DOI: 10.3892/etm.2014.1660
Understanding the polypharmacological anticancer effects of Xiao Chai Hu Tang via a computational pharmacological model
Abstract
Xiao Chai Hu Tang (XCHT), a traditional herbal formula, is widely administered as a cancer treatment. However, the underlying molecular mechanisms of its anticancer effects are not fully understood. In the present study, a computational pharmacological model that combined chemical space mapping, molecular docking and network analysis was employed to predict which chemical compounds in XCHT are potential inhibitors of cancer-associated targets, and to establish a compound-target (C-T) network and compound-compound (C-C) association network. The identified compounds from XCHT demonstrated diversity in chemical space. Furthermore, they occupied regions of chemical space that were the same, or close to, those occupied by drug or drug-like compounds that are associated with cancer, according to the Therapeutic Targets Database. The analysis of the molecular docking and the C-T network demonstrated that the potential inhibitors possessed the properties of promiscuous drugs and combination therapies. The C-C network was classified into four clusters and the different clusters contained various multi-compound combinations that acted on different targets. The study indicated that XCHT has a polypharmacological role in treating cancer and the potential inhibitory components of XCHT require further investigation as potential therapeutic strategies for cancer patients.
Keywords: Xiao Chai Hu Tang; cancer; computational pharmacology; polypharmacology.
Figures




Similar articles
-
Network pharmacology and molecular docking study on the mechanism of colorectal cancer treatment using Xiao-Chai-Hu-Tang.PLoS One. 2021 Jun 14;16(6):e0252508. doi: 10.1371/journal.pone.0252508. eCollection 2021. PLoS One. 2021. PMID: 34125845 Free PMC article.
-
Molecular mechanisms of the Xiao-chai-hu-tang on chronic stress-induced colorectal cancer growth based on an integrated network pharmacology and RNA sequencing approach with experimental validation.BMC Complement Med Ther. 2025 Apr 12;25(1):135. doi: 10.1186/s12906-025-04860-8. BMC Complement Med Ther. 2025. PMID: 40221743 Free PMC article.
-
Xiao-Chai-Hu-Tang Ameliorates Depressive Symptoms via Modulating Neuro-Endocrine Network in Chronic Unpredictable Mild Stress-Induced Mice.CNS Neurosci Ther. 2025 Feb;31(2):e70290. doi: 10.1111/cns.70290. CNS Neurosci Ther. 2025. PMID: 39981856 Free PMC article.
-
Xiao Chai Hu Tang for Peptic Ulcers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Evid Based Complement Alternat Med. 2021 Apr 29;2021:6693677. doi: 10.1155/2021/6693677. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 34012475 Free PMC article. Review.
-
Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula.J Ethnopharmacol. 2020 Apr 6;251:112442. doi: 10.1016/j.jep.2019.112442. Epub 2019 Dec 28. J Ethnopharmacol. 2020. PMID: 31891799 Review.
Cited by
-
Addition and Subtraction Theory of TCM Using Xiao-Chaihu-Decoction and Naturopathy in Predicting Survival Outcomes of Primary Liver Cancer Patients: A Prospective Cohort Study.Evid Based Complement Alternat Med. 2016;2016:4723530. doi: 10.1155/2016/4723530. Epub 2016 Oct 24. Evid Based Complement Alternat Med. 2016. PMID: 27843477 Free PMC article.
-
Association between use of Qingfei Paidu Tang and mortality in hospitalized patients with COVID-19: A national retrospective registry study.Phytomedicine. 2021 May;85:153531. doi: 10.1016/j.phymed.2021.153531. Epub 2021 Feb 28. Phytomedicine. 2021. PMID: 33799224 Free PMC article.
-
Feasibility of the inhibitor development for cancer: A systematic approach for drug design.PLoS One. 2024 Aug 22;19(8):e0306632. doi: 10.1371/journal.pone.0306632. eCollection 2024. PLoS One. 2024. PMID: 39173044 Free PMC article.
References
-
- Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–2917. - PubMed
-
- Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90. - PubMed
-
- Carney DN, Hansen HH. Non-small-cell lung cancer - stalemate or progress? N Engl J Med. 2000;343:1261–1262. - PubMed
-
- Bröker LE, Giaccone G. The role of new agents in the treatment of non-small cell lung cancer. Eur J Cancer. 2002;38:2347–2361. - PubMed
-
- Yang CS, Wang H, Hu B. Combination of chemopreventive agents in nanoparticles for cancer prevention. Cancer Prev Res (Phila) 2013;6:1011–1014. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources